Warning: This security is no longer trading.
Eli Lilly completes acquisition of Dermira
Dermira, Inc. (DERM): Price and Financial Metrics
DERM Price/Volume Stats
| Current price | $7.39 | 52-week high | $8.25 |
| Prev. close | $7.54 | 52-week low | $3.54 |
| Day low | $7.32 | Volume | 55,500 |
| Day high | $7.75 | Avg. volume | 79,949 |
| 50-day MA | $6.88 | Dividend yield | N/A |
| 200-day MA | $5.58 | Market Cap | 172.16M |
DERM Stock Price Chart Interactive Chart >
Dermira, Inc. (DERM) Company Bio
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. The company was founded in 2010 and is based in Menlo Park, California.
DERM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DERM Price Returns
| 1-mo | 7.41% |
| 3-mo | 43.77% |
| 6-mo | 43.22% |
| 1-year | 57.23% |
| 3-year | 96.54% |
| 5-year | N/A |
| YTD | 89.00% |
| 2024 | -32.12% |
| 2023 | 200.00% |
| 2022 | -64.31% |
| 2021 | N/A |
| 2020 | N/A |